Arkolith/Insider Trading/ELYM/Form 4

Morisset Valerie

EVP, R&D AND CSOEliem Therapeutics, Inc. (ELYM) · full profile →Form 4 · filed Jul 19, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$289K
Net Open-Market Flow
-$289K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 18, 2024Sell(S)39K$6.93$267K161K
Jul 17, 2024Sell(S)3K$6.91$22K199K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-019814) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML